The Global Brain Cancer Diagnostics Market presents opportunities in AI-driven precision diagnostics and non-invasive liquid biopsies, driven by an aging population and rising tumor incidences.

Key market opportunities include the rising prevalence of chronic diseases and increased regulatory approvals driving demand ...

The Relational Databases Software Market was valued at USD 45 billion in 2024 and is projected to reach approximately USD 75 billion by 2033, growing at a steady CAGR of 7.5% during the 2026-2033 ...

ASHEVILLE - Thermo Fisher Scientific will close its Asheville-area facility by the end of 2026, the company confirmed to the Citizen Times Jan. 9. First owned by Kendro Laboratory Products, the over ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the J.P. Morgan 2026 ...

Fisher Companies is celebrating 100 years with an open house on Friday, Dec. 5. The open house will be at 3401 Contractor Dr. from 3 p.m. until 6 p.m. This will be the first time the public has been ...

Thermo Fisher Scientific is breaking out the big bills to score a clinical research treat. With $8.875 billion in cash, the life science giant is adding Clario Holdings to its goodie bag, the company ...

Notably, Clario centralizes clinical trial endpoint data from devices, sites and patients, allowing pharma and biotech companies to digitally collect, manage, and analyze evidence across all phases of ...

(Reuters) - Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, strengthening its clinical trial research business amid a strong rebound ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a definitive agreement to acquire Clario Holdings, Inc., a leading ...

(Reuters) -Medical equipment maker Thermo Fisher is nearing an all-cash takeover of U.S-based Clario in a deal that could value the clinical trial data management company at about $10 billion, the ...